Status:
COMPLETED
Nurse-led Family and Network Consultations
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
The Novo Nordic Foundation
Conditions:
High-grade Glioma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients diagnosed with high-grade gliomas (HGG) experience a complex symptom burden including high-levels concerns. As a consequence to this life-threatening disease, the rely on close contact with ...
Detailed Description
Objectives To explore the feasibility and benefits of a 'Nurse-led Family and Network Consultation' (FNC) that seek to identify and address patients' symptoms/concerns and caregiver burden on one side...
Eligibility Criteria
Inclusion
- \-
- Patients in the cohort (n=30) and IG (n=30) and their families will be recruited within the first week after surgery. Included are:
- Patients ≥ 18 years of age and newly diagnosed with HGG (WHO classification grade III/IV) after biopsy or operation.
- The patients and their family members and network must be able to speak and understand Danish.
- Provide informed consent
Exclusion
- Excluded are • Patients without family or any network. There are no restrictions regarding the family members/network relation to the patient as long as the patient has accepted the person(s) as being a close relative or friend that the patient allows to participate in the FNC. Written informed consent will be obtained before discharge from the hospital or by telephone after discharge.
Key Trial Info
Start Date :
April 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT03458312
Start Date
April 9 2018
End Date
November 1 2023
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital of Copenhagen, Rigshospitalet
Copenhagen, Denmark, 2100